Enrico Domenici

Enrico Domenici is an accomplished scientist with extensive expertise in neuroscience and computational biology. Currently serving as President of COSBI since November 2017, Enrico is responsible for the scientific and technical strategies of the organization, focusing on research and development of advanced algorithms and computational pipelines. Enrico also holds the position of Full Professor at the Università di Trento, leading the Laboratory of Neurogenomic Biomarkers and investigating genetic determinants related to CNS pathologies and innovative therapies. Additionally, Enrico contributes as Field Chief Editor for Frontiers in Genetics and previously held significant roles at Roche Pharmaceuticals and GSK, where Enrico specialized in biomarker research and translational medicine. Enrico Domenici earned a PhD in Chemistry from Scuola Normale Superiore and a degree in Biological Sciences from Università di Pisa.